Literature DB >> 31376674

Severe asthma: Comparison of different classifications of severity and control.

Alexssandra Maia Alves1, Luane Marques de Mello2, Aline Silva Lima Matos3, Álvaro Augusto Cruz3.   

Abstract

BACKGROUND: Criteria of asthma severity and control lack standardization.
OBJECTIVE: to compare classifications of asthma severity and control, applied to patients from a severe asthma clinic.
METHODS: Cross-sectional study of 473 patients followed up for ≥6 months, reclassified using three criteria: 1) the World Health Organization (WHO) 2010, 2) the American Thoracic Society (ATS) 2000, and 3) the European Respiratory Society (ERS)/ATS 2014. In order to evaluate disease control, the 2012 and 2014 Global Initiative for Asthma (GINA) classifications were compared.
RESULTS: According to the definition of WHO 2010, 429 had Difficult-to-treat severe asthma and only 12 presented Treatment-resistant severe asthma. 114 patients had Refractory asthma by ATS 2000 and 88 had Severe asthma by ERS/ATS 2014. Considering the definitions of WHO 2010, only 9 out of 12 with Treatment-resistant and 64 out of 429 with Difficult-to-treat severe asthma met the criteria of ATS 2000 and ERS/ATS 2014. As for GINA classification of control, 208 (44%) of the 473 subjects were classified as having asthma controlled by the 2014 criteria, whereas only 45 (10%) patients had controlled asthma by the GINA 2012 criteria. The Kappa statistic indicates the highest agreement of the severity classification occurred between the criteria of ATS 2000 and ERS/ATS 2014 (0.64).
CONCLUSION: Good agreement was found between Refractory asthma ATS 2000 and Severe asthma ERS/ATS 2014 classifications. However, poor agreement was observed between the severity rating proposed by the WHO and other classifications. The GINA control classifications of 2012 and 2014 also agreed poorly.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Asthma; Classifications; Disease management; Therapy

Year:  2019        PMID: 31376674     DOI: 10.1016/j.rmed.2019.07.015

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  2 in total

1.  Risk factors for severe adult-onset asthma: a multi-factor approach.

Authors:  Sanna Toppila-Salmi; Riikka Lemmetyinen; Sebastien Chanoine; Jussi Karjalainen; Juha Pekkanen; Jean Bousquet; Valérie Siroux
Journal:  BMC Pulm Med       Date:  2021-07-08       Impact factor: 3.317

2.  Biseugenol Exhibited Anti-Inflammatory and Anti-Asthmatic Effects in an Asthma Mouse Model of Mixed-Granulocytic Asthma.

Authors:  Vitor Ponci; Rafael C Silva; Fernanda Paula R Santana; Simone S Grecco; Célia Regina M Fortunato; Maria A Oliveira; Wothan Tavares-de-Lima; Clarice R Olivo; Iolanda de Fátima L Calvo Tibério; Kaio S Gomes; Carla M Prado; João Henrique G Lago
Journal:  Molecules       Date:  2020-11-18       Impact factor: 4.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.